Tet2 Is a Novel Regulator of Murine Macrophage Differentiation and Polarization

被引：0
|
作者：
Cull, Alyssa [1 ]
Snetsinger, Brooke [1 ]
Rauh, Michael J. [2 ]
机构：
[1] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada
[2] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] TET2 Favors Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells
    Mor, Barbara Da Costa Reis Monte
    Langlois, Thierry
    Droin, Nathalie
    Pronier, Elodie
    Le Couedic, Jean-Pierre
    Auger, Nathalie
    Almire, Carole
    Mercher, Thomas
    Delhommeau, Francois
    Najet, Debili
    Bernard, Olivier
    Solary, Eric
    Plo, Isabelle
    Vainchenker, William
    BLOOD, 2011, 118 (21) : 1039 - 1040
  • [42] tet2 and tet3 regulate cell fate specification and differentiation events during retinal development
    Heilman, Shea A.
    Schriever, Hannah C.
    Kostka, Dennis
    Koenig, Kristen M.
    Gross, Jeffrey M.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [43] A novel TET2 mutation in a patient with refractory cytopenia with multilineage dysplasia
    Coutinho, D. F.
    Diniz, C.
    Filgueiras, R. L. D.
    Baptista, R. L. R.
    Ayres-Silva, J. P.
    Monte-Mor, B. C. R.
    Bonamino, M. H.
    Zalcberg, I. R.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04) : 5858 - 5862
  • [44] Impact of Tet2 Deficiency, and of TET2 Mutations in Clonal Hematopoiesis, on Neutrophil/Granulocyte Immune Function
    Cook, Elina K.
    Luo, Michael
    Mewburn, Jeffrey
    Dunham-Snary, Kimberly J.
    Hindmarch, Charles
    Archer, Stephen L.
    Rauh, Michael J.
    BLOOD, 2021, 138
  • [45] Dysregulation of TET2 in hematologic malignancies
    Shigeru Chiba
    International Journal of Hematology, 2017, 105 : 17 - 22
  • [46] Golgi Phosphoprotein 2 Is a Novel Regulator of IL-12 Production and Macrophage Polarization
    Zhang, Wei
    Kim, Hajeong
    Lv, Jiyang
    Zhao, Na
    Ma, Xiaojing
    JOURNAL OF IMMUNOLOGY, 2018, 200 (04): : 1480 - 1488
  • [47] TET2, an “ambiguous” player in inflammation
    Ana María Espinosa-Oliva
    Miguel Angel Burguillos
    NeuralRegenerationResearch, 2020, 15 (08) : 1481 - 1482
  • [48] The Potential Equivalents of TET2 Mutations
    Pasca, Sergiu
    Jurj, Ancuta
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CANCERS, 2021, 13 (07)
  • [49] TET2 mutations in childhood leukemia
    Langemeijer, S. M. C.
    Jansen, J. H.
    Hooijer, J.
    van Hoogen, P.
    Stevens-Linders, E.
    Massop, M.
    Waanders, E.
    van Reijmersdal, S. V.
    Stevens-Kroef, M. J. P. L.
    Zwaan, C. M.
    van den Heuvel-Eibrink, M. M.
    Sonneveld, E.
    Hoogerbrugge, P. M.
    van Kessel, A. Geurts
    Kuiper, R. P.
    LEUKEMIA, 2011, 25 (01) : 189 - 192
  • [50] Mutation in TET2 in Myeloid Cancers
    Delhommeau, Francois
    Dupont, Sabrina
    Della Valle, Veronique
    James, Chloe
    Trannoy, Severine
    Masse, Aline
    Kosmider, Olivier
    Le Couedic, Jean-Pierre
    Robert, Fabienne
    Alberdi, Antonio
    Lecluse, Yann
    Plo, Isabelle
    Dreyfus, Francois J.
    Marzac, Christophe
    Casadevall, Nicole
    Lacombe, Catherine
    Romana, Serge P.
    Dessen, Philippe
    Soulier, Jean
    Viguie, Franck
    Fontenay, Michaela
    Vainchenker, William
    Bernard, Olivier A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2289 - 2301
12345